BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 8358706)

  • 21. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
    Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
    J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.
    Lozniewski A; Rabaud C; Dotto E; Weber M; Mory F
    J Clin Microbiol; 2001 May; 39(5):1996-8. PubMed ID: 11326033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of multiplex PCR with enhanced spore germination for detection of Clostridium difficile from stool samples of the hospitalized patients.
    Chankhamhaengdecha S; Hadpanus P; Aroonnual A; Ngamwongsatit P; Chotiprasitsakul D; Chongtrakool P; Janvilisri T
    Biomed Res Int; 2013; 2013():875437. PubMed ID: 23586062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea.
    Jacobs J; Rudensky B; Dresner J; Berman A; Sonnenblick M; van Dijk Y; Yinnon AM
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):561-6. PubMed ID: 8874073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.
    Merz CS; Kramer C; Forman M; Gluck L; Mills K; Senft K; Steiman I; Wallace N; Charache P
    J Clin Microbiol; 1994 May; 32(5):1142-7. PubMed ID: 8051237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence.
    Joshi LT; Mali BL; Geddes CD; Baillie L
    PLoS One; 2014; 9(8):e104334. PubMed ID: 25162622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a commercial latex agglutination assay for screening for Clostridium difficile-associated disease.
    Stella PA
    Clin Lab Sci; 1994; 7(5):311-3. PubMed ID: 10150387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.
    Kelly MT; Champagne SG; Sherlock CH; Noble MA; Freeman HJ; Smith JA
    J Clin Microbiol; 1987 Jul; 25(7):1244-7. PubMed ID: 3611316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests.
    Shanholtzer CJ; Willard KE; Holter JJ; Olson MM; Gerding DN; Peterson LR
    J Clin Microbiol; 1992 Jul; 30(7):1837-40. PubMed ID: 1629341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital.
    Martirosian G; Kuipers S; Verbrugh H; van Belkum A; Meisel-Mikolajczyk F
    J Clin Microbiol; 1995 Aug; 33(8):2016-21. PubMed ID: 7559940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory diagnosis of Clostridium difficile infection.
    Goldenberg SD; Cliff PR; French GL
    J Clin Microbiol; 2010 Aug; 48(8):3048-9. PubMed ID: 20668301
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.
    Gilligan PH; Walden TP; Kelly WF; Wait KJ; Kraft JA; Willis DH
    Arch Pathol Lab Med; 1993 May; 117(5):507-10. PubMed ID: 8489340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase.
    Lyerly DM; Barroso LA; Wilkins TD
    J Clin Microbiol; 1991 Nov; 29(11):2639-42. PubMed ID: 1774279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals.
    Karasawa T; Nojiri T; Hayashi Y; Maegawa T; Yamakawa K; Wang XM; Nakamura S
    J Gastroenterol; 1999 Feb; 34(1):41-5. PubMed ID: 10204609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.
    Doern GV; Coughlin RT; Wu L
    J Clin Microbiol; 1992 Aug; 30(8):2042-6. PubMed ID: 1500512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A particle counting immunoassay for the direct detection of Clostridium difficile serogroup specific antigen in faecal specimens.
    Avesani A; Cambiaso C; Guarin JL; Lick A; Delmée M
    J Med Microbiol; 1994 Apr; 40(4):270-4. PubMed ID: 8151678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clostridium difficile infection: epidemiology, risk factors, pathogenesis, clinical features, diagnosis and therapy].
    Kılıç A
    Mikrobiyol Bul; 2013 Jul; 47(3):556-66. PubMed ID: 23971935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.